Brief: Adicet Bio Q4 Basic EPS USD -2.94
12/03/2026 20:00
Mar 12 (Reuters) - Adicet Bio Q4 operating expenses USD 31.885 million. Q4 net income USD -30.516 million Q4 operating income USD -31.885 million
Recent news on ADICET Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Adicet Bio Announces Positive Safety And Efficacy Data From Prula-Cel (Formerly Adi-001) Study In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis
Brief: Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212
Adicet Bio, Inc. Reports Results For The Quarter Ended June 30: Earnings Summary